Daniel Arber to Pyrimidines
This is a "connection" page, showing publications Daniel Arber has written about Pyrimidines.
Connection Strength
0.087
-
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood. 2003 Jun 15; 101(12):4701-7.
Score: 0.046
-
Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance. Blood Adv. 2021 09 14; 5(17):3492-3496.
Score: 0.041